| Symbol | ZBIO |
|---|---|
| Name | ZENAS BIOPHARMA, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1000 WINTER ST,SUITE 1200, WALTHAM, Massachusetts, 02451, United States |
| Telephone | 857-271-2954 |
| Fax | — |
| — | |
| Website | https://www.zenasbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001953926 |
| Description | Zenas BioPharma is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need. We leverage our experienced executive management team and our established networks throughout the biopharmaceutical industry to identify, acquire and develop product candidates that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Our lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We are developing obexelimab for patients in several autoimmune diseases. Additional info from NASDAQ: |
📋 Zebra Aggregator, LP (Affiliate) plans to sell 1.0M shares of ZENAS BIOPHARMA INC (at $31.91 each, total $31.9M) Filed: Aug 19, 2026 | ID: 000858
Read moreNew Form SCHEDULE 13D/A - Zenas BioPharma, Inc. <b>Filed:</b> 2026-08-19 <b>AccNo:</b> 0001953107-26-000015 <b>Size:</b> 9 KB
Read moreZenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreNew Form SCHEDULE 13D/A - Zenas BioPharma, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001072613-26-000694 <b>Size:</b> 153 KB
Read moreZenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreNunn Jason Raleigh 🟢 acquired 18.5K shares (1 derivative) of Zenas BioPharma, Inc. (ZBIO) at $18.71 Transaction Date: Jun 15, 2026 | Filing ID: 274473
Read moreDirector Lu Hongbo 🟢 acquired 18.5K shares (1 derivative) of Zenas BioPharma, Inc. (ZBIO) at $18.71 Transaction Date: Jun 15, 2026 | Filing ID: 075257
Read moreDirector MOULDER LEON O JR 🟢 acquired 500.0K shares (1 derivative) of Zenas BioPharma, Inc. (ZBIO) at $18.71 ($9.4M) Transaction Date: Jun 15, 2026 | Filing ID: 075256
Read moreDirector ORLOFF JOHN J 🟢 acquired 18.5K shares (1 derivative) of Zenas BioPharma, Inc. (ZBIO) at $18.71 Transaction Date: Jun 15, 2026 | Filing ID: 075255
Read morevon Moltke Lisa 🟢 acquired 150.0K shares (1 derivative) of Zenas BioPharma, Inc. (ZBIO) at $18.71 ($2.8M) Transaction Date: Jun 15, 2026 | Filing ID: 075254
Read more